指南与共识产科母胎医学

母胎医学会咨询系列#71:不可存活期与围存活期未足月胎膜早破的管理

Society for Maternal-Fetal Medicine Consult Series #71: Management of previable and periviable preterm prelabor rupture of membranes.
指南 / 共识 · Am J Obstet Gynecol · 2024-07-16

本咨询系列针对不可存活期与围存活期未足月胎膜早破的管理提出7条推荐,涵盖个体化咨询与 abortion care(GRADE 1C)、≥24 0/7周期待治疗时使用抗生素(GRADE 1B)、20 0/7至23 6/7周可考虑抗生素(GRADE 2C)、不推荐产前皮质激素与硫酸镁(GRADE 1B)、羊膜腔灌注与羊膜补片仅限临床试验(GRADE 1B)、环扎带处理(GRADE 2C)及后续妊娠管理(GRADE 1C)。

要点

  • 所有不可存活期与围存活期胎膜早破患者均应获得 abortion care 选择,无禁忌时可提供期待治疗(GRADE 1C)。
  • ≥24 0/7周期待治疗者推荐抗生素(GRADE 1B);20 0/7至23 6/7周可考虑抗生素(GRADE 2C)。
  • 在医疗团队认为适合且患者 desired 新生儿复苏试验前,不推荐产前皮质激素与硫酸镁(GRADE 1B)。

核心结论

  • 不可存活期与围存活期胎膜早破管理需个体化咨询,提供 abortion care 与期待治疗选择,并按孕周分层给予抗生素、不推荐产前皮质激素与硫酸镁、羊膜腔灌注与羊膜补片仅限临床试验、环扎带处理可移除或留置、后续妊娠按既往自发性早产指南管理。

研究设计与样本

  • 母胎医学会(Society for Maternal-Fetal Medicine)发布的咨询系列#71,以 GRADE 分级给出7条推荐。

主要发现

  • 推荐所有不可存活期与围存活期胎膜早破患者接受个体化咨询并 offer abortion care,无禁忌时可 offer 期待治疗(GRADE 1C)。
  • 推荐≥24 0/7周期待治疗者使用抗生素(GRADE 1B);20 0/7至23 6/7周可考虑抗生素(GRADE 2C)。
  • 不推荐在医疗团队认为适合且患者 desired 新生儿复苏试验前给予产前皮质激素与硫酸镁(GRADE 1B)。
  • 系列羊膜腔灌注与羊膜补片被认为处于研究阶段,仅限临床试验使用,不推荐用于常规 care(GRADE 1B)。
  • 环扎带处理与较大孕周胎膜早破相似,讨论风险获益并共享决策后可移除或留置(GRADE 2C);后续妊娠推荐遵循既往自发性早产管理指南(GRADE 1C)。

关键数值与推荐

  • GRADE 1C:个体化咨询并提供 abortion care,无禁忌时可 offer 期待治疗。
  • GRADE 1B:≥24 0/7周期待治疗推荐抗生素;不推荐产前皮质激素与硫酸镁;羊膜腔灌注与羊膜补片仅限临床试验。
  • GRADE 2C:20 0/7至23 6/7周可考虑抗生素;环扎带可移除或留置。
  • GRADE 1C:后续妊娠遵循既往自发性早产管理指南。

临床怎么用

  • 对所有不可存活期与围存活期胎膜早破患者进行个体化咨询,提供 abortion care 与期待治疗选择(GRADE 1C)。
  • 期待治疗者按孕周给予抗生素:≥24 0/7周推荐(GRADE 1B),20 0/7至23 6/7周可考虑(GRADE 2C)。
  • 在医疗团队认为适合且患者 desired 新生儿复苏试验前,不给予产前皮质激素与硫酸镁(GRADE 1B)。
  • 羊膜腔灌注与羊膜补片仅限临床试验,不用于常规 care(GRADE 1B)。
  • 环扎带可移除或留置,需共享决策(GRADE 2C);后续妊娠按既往自发性早产指南管理(GRADE 1C)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previable and periviable preterm prelabor rupture of membranes are challenging obstetrical complications to manage given the substantial risk of maternal morbidity and mortality, with no guarantee of fetal benefit. The following are the Society for Maternal-Fetal Medicine recommendations for the management of previable and periviable preterm prelabor rupture of membranes before the period when a trial of neonatal resuscitation and intensive care would be considered appropriate by the healthcare team and desired by the patient: (1) we recommend that pregnant patients with previable and periviable preterm prelabor rupture of membranes receive individualized counseling about the maternal and fetal risks and benefits of both abortion care and expectant management to guide an informed decision; all patients with previable and periviable preterm prelabor rupture of membranes should be offered abortion care, and expectant management can also be offered in the absence of contraindications (GRADE 1C); (2) we recommend antibiotics for pregnant individuals who choose expectant management after preterm prelabor rupture of membranes at ≥24 0/7 weeks of gestation (GRADE 1B); (3) antibiotics can be considered after preterm prelabor rupture of membranes at 20 0/7 to 23 6/7 weeks of gestation (GRADE 2C); (4) administration of antenatal corticosteroids and magnesium sulfate is not recommended until the time when a trial of neonatal resuscitation and intensive care would be considered appropriate by the healthcare team and desired by the patient (GRADE 1B); (5) serial amnioinfusions and amniopatch are considered investigational and should be used only in a clinical trial setting; they are not recommended for routine care of previable and periviable preterm prelabor rupture of membranes (GRADE 1B); (6) cerclage management after previable or periviable preterm prelabor rupture of membranes is similar to cerclage management after preterm prelabor rupture of membranes at later gestational ages; it is reasonable to either remove the cerclage or leave it in situ after discussing the risks and benefits and incorporating shared decision-making (GRADE 2C); and (7) in subsequent pregnancies after a history of previable or periviable preterm prelabor rupture of membranes, we recommend following guidelines for management of pregnant persons with a previous spontaneous preterm birth (GRADE 1C).

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Battarbee AN, Osmundson SS, McCarthy AM, et al. Society for Maternal-Fetal Medicine Consult Series #71: Management of previable and periviable preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2024. PMID: 39025459. doi:10.1016/j.ajog.2024.07.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。